Pediatric brain tumors: Update of proteome-based studies

Journal of Proteomics
G T Tsangaris, A K Anagnostopoulos

Abstract

Pediatric brain tumors (PBTs) are the most common solid malignancies in childhood and continue to pose a serious burden to modern societies. Existing treatments impose debilitating effects on the developing child, highlighting the need for molecularly targeted treatments with reduced toxicity, as well as the necessity of markers that reliably assess efficacy of, and tumor response to targeted-therapies of PBTs. On this regard advances in technologies of protein identification and quantification, the large-scale, high-throughput investigation of the proteome, as well the newly-emerging field of "proteogenomics" aim to further our knowledge towards understanding the molecular pathophysiology of PBTs. This mini review article presents all updates on knowledge produced and published during the last years on PBT research derived from "omics" technologies, mainly involving protein research and proteomics.

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Related Papers

Expert Review of Neurotherapeutics
Melissa J SiegelStergios Zacharoulis
Current Opinion in Allergy and Clinical Immunology
Denyse GautrinRoberto Castano
Current Opinion in Chemical Biology
Matthew Bogyo, Pauline M Rudd
© 2022 Meta ULC. All rights reserved